HALK Cafe - II

[bahriyeli]

Prof. Dr. Ercüment Ovalý 23 Nisan'ý beklemeyip ilacý duyurdu: Çok etkili, acilen kullanýlmalý
Son dakika haberi: Türkiye'de ve dünyada corona aþýsý ve tedavisi için çalýþmalar hýz kesmeden devam ediyor. Aþý ve tedavi geliþtirmek için çalýþmalar yapan Prof. Dr. Ercüment Ovalý'dan heyecanlandýran açýklama geldi.

http://www.haber7.com/guncel/haber/2...n-kullanilmali

hadi bakalým inþallah neden olmasýn

[Zdx&Lunar Soul]

ZDX sen ne dusunuyorsun bu araci kurum islemleri ile ilgili? Araci kurumda calismisligin vardi hatirladigim kadariyla. Cok fazla araci kurumlarin kendi fonlari da gunluk islem yapiyor mu?

Daha jübilene en az 3-5 ay var.Cam ý ile ilgilendiðin kadar sahibi ve o sektörlede ilgileniver.Var, yapar.Ama uzaðým çok uzun zamandýr o konulara.

[mrtk]

Evin karþýsýnda Ýstanbul'un en büyük projelerinden biri baþlamýþtý geçen sene, yaklaþýk 1.5 senedir de durmuþtu inþaat. Þantiyeye adam bile gelmiyordu. Yüksek katta oturduðumdan tüm olaya hakimim. Þey olayý baþladýðýndan beri bu ekonomiye raðmen adamlar gece gündüz çalýþmaya baþladýlar, Mart ortasýndan itibaren. Önceden mi planlandý yoksa baþka bir þey mi var bilmiyorum. Yorum yapabilecek olan var mý ? Ben bu inþaat batar diye düþünüyordum.

[666]

Devlet tesvik mi sagladi diyorsun mrtk?

[666]

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

By Adam Feuerstein and Matthew Herper

April 16, 2020


Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.

Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests. The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies. If safe and effective, it could become the first approved treatment against the disease.

The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir.

[mrtk]

Early peek at data on Gilead coronavirus drug suggests patients are responding to treatment

By Adam Feuerstein and Matthew Herper

April 16, 2020


Chicago hospital treating severe Covid-19 patients with Gilead Sciences’ antiviral medicine remdesivir in a closely watched clinical trial is seeing rapid recoveries in fever and respiratory symptoms, with nearly all patients discharged in less than a week, STAT has learned.

Remdesivir was one of the first medicines identified as having the potential to impact SARS-CoV-2, the novel coronavirus that causes Covid-19, in lab tests. The entire world has been waiting for results from Gilead’s clinical trials, and positive results would likely lead to fast approvals by the Food and Drug Administration and other regulatory agencies. If safe and effective, it could become the first approved treatment against the disease.

The University of Chicago Medicine recruited 125 people with Covid-19 into Gilead’s two Phase 3 clinical trials. Of those people, 113 had severe disease. All the patients have been treated with daily infusions of remdesivir.

Ýlaç üstüne ilaç bulunuyor, bizimkiler de buldu birþeyler hadi baklaým inþallah...

[mrtk]

Devlet tesvik mi sagladi diyorsun mrtk?

Bilmiyorum iþte soruyorum, Dolar 7 lira olmuþ, resesyon geliyor adamlar inþaata baþladý.

[666]

Ha bak bunu dusunmedim. Ceza almis olabilir. Pek iyi hallliydi, kavgasi olmazdi, o yuzden pek dusunmedim.

Dusunmustum. Cezali degil KIZILDAG, mesaj atmistim. Umarim bir terslik yoktur.